

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb70652</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Identification of a Novel Nucleic Acid Target for the Rapid and Specific Detection  of Mycobacterium Simiae Using Comparative Genomic Analysis </article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Kamali Kakhki</surname><given-names>Reza</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Abavisani </surname><given-names>Mohammad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ghazvini </surname><given-names>Kiarash</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Zare</surname><given-names>Hosna</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Hojatpanah </surname><given-names>Noshin</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Falahi </surname><given-names>Jamal</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Neshani</surname><given-names>Alireza</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>18</volume>
      <issue>2</issue>
      <fpage>157</fpage>
      <lpage>166</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>9</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>1</month>
          <year>2026</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Background: Mycobacterium simiae (M. simiae) is a non-tuberculous mycobacterium (NTM) that closely resembles Mycobacterium tuberculosis (M. tuberculosis) in clinical and biochemical characteristics, notably its niacin-positive phenotype. This similarity frequently leads to misdiagnosis and inappropriate treatment with first-line anti-tuberculosis drugs, to which M. simiae is frequently resistant. Current diagnostic methods are expensive or need complex equipment, highlighting the urgent need for a rapid, specific, and accessible molecular target to identify M. simiae accurately.&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Methods: In this study, a modified genome comparison method was applied to the complete reference genome of M. simiae (AP022568.1) in order to identify a putative species-specific nucleotide sequence. A conventional PCR assay was designed to amplify a 168-bp fragment within this target, designated MST601 (M. simiae Target, 601 bp). The analytical sensitivity [Limit of Detection (LOD)] was determined using serial dilutions of genomic DNA. The pilot evaluation of the assay was assessed using 10 well-characterized clinical isolates of M. simiae. &lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Results: The MST601-PCR assay demonstrated high analytical sensitivity, with a limit of detection of ~10 fg (&amp;asymp;2 genome equivalents per reaction) of M. simiae genomic DNA. No cross-reactivity among the tested species was observed with any of the 10 non-target mycobacterial species tested. The assay successfully amplified the target sequence from all 10 clinical isolates. Sequencing of the amplicons revealed &amp;ge;99% identity to reference M. simiae strains in the GenBank database, validating the assay&amp;#39;s accuracy.&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Conclusion: A species-specific nucleic acid target, MST601, facilitating the rapid and accurate detection of M. simiae via conventional PCR was presented. This assay pro-vides a low-cost and accessible option for diagnostic laboratories.&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
